Cargando…
PB1857: NRF2 MODULATORS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A POSSIBLE NEW THERAPEUTIC APPROACH
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429100/ http://dx.doi.org/10.1097/01.HS9.0000850280.27434.98 |
_version_ | 1784779329393131520 |
---|---|
author | Carda #, J. P. Gomes #, R. Jorge, J. Gonçalves, A. C. Marques, B. Alves, R. Sarmento-Ribeiro, A. B. |
author_facet | Carda #, J. P. Gomes #, R. Jorge, J. Gonçalves, A. C. Marques, B. Alves, R. Sarmento-Ribeiro, A. B. |
author_sort | Carda #, J. P. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9429100 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-94291002022-08-31 PB1857: NRF2 MODULATORS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A POSSIBLE NEW THERAPEUTIC APPROACH Carda #, J. P. Gomes #, R. Jorge, J. Gonçalves, A. C. Marques, B. Alves, R. Sarmento-Ribeiro, A. B. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429100/ http://dx.doi.org/10.1097/01.HS9.0000850280.27434.98 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Carda #, J. P. Gomes #, R. Jorge, J. Gonçalves, A. C. Marques, B. Alves, R. Sarmento-Ribeiro, A. B. PB1857: NRF2 MODULATORS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A POSSIBLE NEW THERAPEUTIC APPROACH |
title | PB1857: NRF2 MODULATORS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A POSSIBLE NEW THERAPEUTIC APPROACH |
title_full | PB1857: NRF2 MODULATORS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A POSSIBLE NEW THERAPEUTIC APPROACH |
title_fullStr | PB1857: NRF2 MODULATORS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A POSSIBLE NEW THERAPEUTIC APPROACH |
title_full_unstemmed | PB1857: NRF2 MODULATORS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A POSSIBLE NEW THERAPEUTIC APPROACH |
title_short | PB1857: NRF2 MODULATORS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A POSSIBLE NEW THERAPEUTIC APPROACH |
title_sort | pb1857: nrf2 modulators in chronic lymphocytic leukemia patients: a possible new therapeutic approach |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429100/ http://dx.doi.org/10.1097/01.HS9.0000850280.27434.98 |
work_keys_str_mv | AT cardajp pb1857nrf2modulatorsinchroniclymphocyticleukemiapatientsapossiblenewtherapeuticapproach AT gomesr pb1857nrf2modulatorsinchroniclymphocyticleukemiapatientsapossiblenewtherapeuticapproach AT jorgej pb1857nrf2modulatorsinchroniclymphocyticleukemiapatientsapossiblenewtherapeuticapproach AT goncalvesac pb1857nrf2modulatorsinchroniclymphocyticleukemiapatientsapossiblenewtherapeuticapproach AT marquesb pb1857nrf2modulatorsinchroniclymphocyticleukemiapatientsapossiblenewtherapeuticapproach AT alvesr pb1857nrf2modulatorsinchroniclymphocyticleukemiapatientsapossiblenewtherapeuticapproach AT sarmentoribeiroab pb1857nrf2modulatorsinchroniclymphocyticleukemiapatientsapossiblenewtherapeuticapproach |